Importance of perfusion in myocardial viability studies using delayed contrast-enhanced magnetic resonance imaging

Journal of Magnetic Resonance Imaging

Volumn 24, Issue 1, 2006, Pages 77-83

  Hedström, Erik ^a,c   Arheden, Håkan ^a   Eriksson, Rolf ^b   Johansson, Lars ^b   Ahlstrom, Hâkan ^b   Bjerner, Tomas ^b  

^a LUND UNIVERSITY   (Sweden)

^b UPPSALA UNIVERSITY   (Sweden)

^c LUND UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Ischemia; Magnetic resonance imaging; Myocardial infarction; Myocardial perfusion; Myocardial viability

Indexed keywords

CONTRAST MEDIUM; GADOLINIUM PENTETATE; NUCLEAR MAGNETIC RESONANCE IMAGING AGENT;

ACUTE CORONARY SYNDROME; ANGIOCARDIOGRAPHY; ANIMAL EXPERIMENT; ARTICLE; CONTRAST ENHANCEMENT; CORONARY ARTERY BLOOD FLOW; DIAGNOSTIC IMAGING; FEMALE; HEART INFARCTION; HEART MUSCLE; LEFT ANTERIOR DESCENDING CORONARY ARTERY; MALE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; SWINE;

ANIMALS; CONTRAST MEDIA; CORONARY DISEASE; CORONARY VESSELS; FEMALE; GADOLINIUM; ISCHEMIA; MAGNETIC RESONANCE IMAGING; MALE; MYOCARDIAL INFARCTION; MYOCARDIUM; PERFUSION; SWINE; TIME FACTORS;

EID: 33745686048     PISSN: 10531807     EISSN: 15222586     Source Type: Journal    
DOI: 10.1002/jmri.20604     Document Type: Article

References (30)

1. Hillenbrand HB, Kim RJ, Parker MA, Fieno DS, Judd RM. Early assessment of myocardial salvage by contrast-enhanced magnetic resonance imaging. Circulation 2000;102:1678-1683.
2. Choi KM, Kim RJ, Gubernikoff G, Vargas JD, Parker M, Judd RM. Transmural extent of acute myocardial infarction predicts long-term improvement in contractile function. Circulation 2001;104: 1101-1107.
3. Flacke SJ, Fischer SE, Lorenz CH. Measurement of the gadopentetate dimeglumine partition coefficient in human myocardium in vivo: normal distribution and elevation in acute and chronic infarction, Radiology 2001;218:703-710.
4. Klein C, Nekolla SG, Balbach T, et al. The influence of myocardial blood flow and volume of distribution on late Gd-DTPA kinetics in ischemic heart failure. J Magn Reson Imaging 2004;20:588-594.
5. Tong CY, Prato FS, Wisenberg G, et al. Measurement of the extraction efficiency and distribution volume for Gd-DTPA in normal and diseased canine myocardium. Magn Reson Med 1993;30:337-346.
6. Saeed M, Wendland MF, Masui T, Higgins CB. Reperfused myocardial infarctions on T1- and susceptibility-enhanced MRI: evidence for loss of compartmentalization of contrast media. Magn Reson Med 1994;31:31-39.
7. Arheden H, Saeed M, Higgins CB, et al. Measurement of the distribution volume of gadopentetate dimeglumine at echo-planar MR imaging to quantify myocardial infarction: comparison with 99mTc-DTPA autoradiography in rats. Radiology 1999;211:698-708.
8. Simonetti OP, Kim RJ, Fieno DS, et al. An improved MR imaging technique for the visualization of myocardial infarction. Radiology 2001;218:215-223.
9. McNamara MT, Tscholakoff D, Revel D, et al. Differentiation of reversible and irreversible myocardial injury by MR imaging with and without gadolinium-DTPA. Radiology 1986;158:765-769.
10. Judd RM, Lugo-Olivieri CH, Aral M, et al. Physiological basis of myocardial contrast enhancement in fast magnetic resonance images of 2-day-old reperfused canine infarcts. Circulation 1995;92: 1902-1910.
11. Kim RJ, Chen EL, Lima JA, Judd RM, Myocardial Gd-DTPA kinetics determine MRI contrast enhancement and reflect the extent and severity of myocardial injury after acute reperfused infarction. Circulation 1996;94:3318-3326.
12. Dendale P, Franken PR, Meusel M, van der Geest R, de Roos A. Distinction between open and occluded infarct-related arteries using contrast-enhanced magnetic resonance imaging. Am J Cardiol 1997;80:334-336.
13. Schwitter J, Saeed M, Wendland MF, et al. Influence of severity of myocardial injury on distribution of macromolecules: extravascular versus intravascular gadolinium-based magnetic resonance contrast agents. J Am Coll Cardiol 1997;30:1086-1094.
14. Decking UK, Pai VM, Wen H, Balaban RS. Does binding of Gd-DTPA to myocardial tissue contribute to late enhancement in a model of acute myocardial infarction? Magn Reson Med 2003;49:168-171.
15. Doherty PW, Lipton MJ, Berninger WH, Skioldebrand CG, Carlsson E, Redington RW. Detection and quantitation of myocardial infarction in vivo using transmission computed tomography. Circulation 1981;63:597-606.
16. Higgins CB, Hagen PL, Newell JD, Schmidt WS, Haigler FH. Contrast enhancement of myocardial infarction: dependence on necrosis and residual blood flow and the relationship to distribution of scintigraphic imaging agents. Circulation 1982;65:739-746.
17. Masui T, Saeed M, Wendland MF, Higgins CB. Occlusive and reperfused myocardial infarcts: MR imaging differentiation with non-ionic Gd-DTPA-BMA. Radiology 1991;181:77-83.
18. Yu KK, Saeed M, Wendland MF, et al. Comparison of T1-enhancing and magnetic susceptibility magnetic resonance contrast agents for demarcation of the jeopardy area in experimental myocardial infarction. Invest Radiol 1993;28:1015-1023.
19. Nilsson S, Wikstrom G, Ericsson A, Wikstrom M, Waldenstrom A, Hemmingsson A. MR imaging of gadolinium-DTPA-BMA-enhanced reperfused and nonreperfused porcine myocardial infarction. Acta Radiol 1995;36:633-640.
20. Bremerich J, Wendland MF, Arheden H, et al. Microvascular injury in reperfused infarcted myocardium: noninvasive assessment with contrast-enhanced echoplanar magnetic resonance imaging. J Am Coll Cardiol 1998;32:787-793.
21. Sjoquist PO, Duker G, Almgren O. Distribution of the collateral blood flow at the lateral border of the ischemic myocardium after acute coronary occlusion in the pig and the dog. Basic Res Cardiol 1984;79:164-175.
22. Bjerner T, Wikstrom G, Johansson L, Ahlstrom H. High in-plane resolution T2-weighted magnetic resonance imaging of acute myocardial ischemia in pigs using the Intravascular contrast agent NC100150 injection. Invest Radiol 2004;39:470-478.
23. Fishbein MC, Meerbaum S, Rit J, et al. Early phase acute myocardial infarct size quantification: validation of the triphenyl tetrazolium chloride tissue enzyme staining technique. Am Heart J 1981;101:593-600.
24. Look DC, Locker D. Time saving measurement of NMR and EPR relaxation times. Rev Sci Instrum 1970;41:250-251.
25. Bjornerud A, Bjerner T, Johansson LO, Ahlstrom HK. Assessment of myocardial blood volume and water exchange: theoretical considerations and in vivo results. Magn Reson Med 2003;49:828-837.
26. Bjornerud A, Johansson LO, Briley-Saebo K, Ahlstrom HK. Assessment of T1 and T2* effects in vivo and ex vivo using iron oxide nanoparticles in steady state-dependence on blood volume and water exchange. Magn Reson Med 2002;47:461-471.
27. Storey P, Danias PG, Post M, et al. Preliminary evaluation of EVP 1001-1: a new cardiac-specific magnetic resonance contrast agent with kinetics suitable for steady-state imaging of the ischemic heart. Invest Radiol 2003;38:642-652.
28. Wacker CM, Wiesmann F, Bock M, et al. Determination of regional blood volume and intra-extracapillary water exchange in human myocardium using Feruglose: first clinical results in patients with coronary artery disease. Magn Reson Med 2002;47:1013-1016.
29. Reif F. Fundamentals of statistical and thermal physics. New York: McGraw-Hill; 1965.
30. Kellman P, Arai AE, McVeigh ER, Aletras AH. Phase-sensitive inversion recovery for detecting myocardial infarction using gadolinium-delayed hyperenhancement. Magn Reson Med 2002;47:372-383.